Randomized trial to evaluate the safety, tolerability, and immunogenicity of a booster (third dose) of BNT162b2 COVID-19 vaccine coadministered with 20-valent pneumococcal conjugate vaccine in adults ≥65 years old-Reference-Cited by-同舟云学术

Randomized trial to evaluate the safety, tolerability, and immunogenicity of a booster (third dose) of BNT162b2 COVID-19 vaccine coadministered with 20-valent pneumococcal conjugate vaccine in adults ≥65 years old

Published:2023-06 Issue:28 Volume:41 Page:4190-4198
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Fitz-Patrick David^ORCID,Young Mariano,Yacisin Kari,McElwee Kathleen,Belanger Todd^ORCID,Belanger Kelly,Peng Yahong,Lee Dung-Yang,Gruber William C.,Scott Daniel A.^ORCID,Watson Wendy

Funder

Pfizer

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference27 articles.

1. Risk factors for hospitalization, mechanical ventilation, or death among 10131 US veterans with SARS-CoV-2 infection;Ioannou;JAMA Netw Open,2020

2. Age differences in the association of comorbid burden with adverse outcomes in SARS-CoV-2;O'Hare;BMC Geriatr,2021

3. Understanding the burden of pneumococcal disease in adults;Blasi;Clin Microbiol Infect,2012

4. Pneumococcal infection in adults: burden of disease;Drijkoningen;Clin Microbiol Infect,2014

5. A global agenda for older adult immunization in the COVID-19 era: a roadmap for action;Privor-Dumm;Vaccine,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccination against COVID-19 in a post-pandemic era;COVID-19: An Update;2024-09-01

2. Impfungen in der Nephrologie;Die Nephrologie;2024-06-04

3. Vaccination status and disease severity of COVID-19 in different phases of the pandemic;Human Vaccines & Immunotherapeutics;2024-06-04

4. Bacterial Vaccinations in Patients with Chronic Obstructive Pulmonary Disease;Vaccines;2024-02-18